Chemoinformaics analysis of DEGALLOYL-THEASINENSIN-F
| Molecular Weight | 594.525 | nRot | 3 |
| Heavy Atom Molecular Weight | 568.317 | nRig | 34 |
| Exact Molecular Weight | 594.137 | nRing | 6 |
| Solubility: LogS | -4.281 | nHRing | 2 |
| Solubility: LogP | 1.418 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 69 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 4 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 24 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 24 |
| nHA | 13 | APOL | 77.8626 |
| nHD | 11 | BPOL | 29.5554 |
| QED | 0.153 |
| Synth | 4.584 |
| Natural Product Likeliness | 1.548 |
| NR-PPAR-gamma | 0.848 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.045 |
| Pgp-sub | 0 |
| HIA | 0.991 |
| CACO-2 | -6.965 |
| MDCK | 0.00000364 |
| BBB | 0.008 |
| PPB | 0.863952 |
| VDSS | 0.444 |
| FU | 0.104697 |
| CYP1A2-inh | 0.099 |
| CYP1A2-sub | 0.081 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.036 |
| CYP2c9-inh | 0.361 |
| CYP2c9-sub | 0.359 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.201 |
| CYP3a4-inh | 0.064 |
| CYP3a4-sub | 0.059 |
| CL | 14.834 |
| T12 | 0.836 |
| hERG | 0.104 |
| Ames | 0.186 |
| ROA | 0.077 |
| SkinSen | 0.972 |
| Carcinogencity | 0.01 |
| EI | 0.898 |
| Respiratory | 0.016 |
| NR-Aromatase | 0.735 |
| Antiviral | Yes |
| Prediction | 0.790612 |